Interviews - The CPAP (Continuous Positive Airway Pressure) equipment market is about to enter a pivotal time. The Centers for Medicare and Medicaid (CMS) instituted a round … Continue Reading
Read NowLong Ideas - Investors in Ziopharm Oncology (ZIOP) eagerly await the release of top-line data from the phase 3 trial, PICASSO III, of Palifosfamide in first-line metastatic Soft … Continue Reading
Read NowLong Ideas - On the back of sequestration cuts and CMS (Centers for Medicare and Medicaid Services) rate changes, another home healthcare provider has guided for a far … Continue Reading
Read NowLong Ideas - Since late last year when Orexigen (OREX) revealed that its cardiovascular outcomes trial, the LIGHT study, was enrolling faster than anticipated and that the FDA … Continue Reading
Read NowLong Ideas - As investors packed up in search of more exciting prospects, shares of OraSure Technologies (OSUR) have been slashed in half since their highs in mid-2012, … Continue Reading
Read NowLong Ideas - Although Illumina was slapped with a $96M fine by a federal jury this week, the monetary penalty isn’t all that detrimental to the $6B company; … Continue Reading
Read NowLong Ideas - Keryx Biopharmaceuticals’ (KERX) CEO, Ron Bentsur, spent much of the company’s 4Q/YE12 earnings conference call reviewing patents, pending patents, and potential exclusivity designations for Zerenex, … Continue Reading
Read Now